Veterinary Enterprises of Tomorrow Inc. – FDA 483, Jun 3, 2026

Veterinary Enterprises of Tomorrow Inc. in Mountain View, OK, was inspected and received a Form 483 with 13 observations highlighting significant deficiencies in their manufacturing of sterile and non-sterile drug products. Key issues include inadequate validation of aseptic processes, lack of environmental and personnel monitoring, unvalidated cleaning and sterilization procedures, deficient laboratory controls, and incomplete batch records. These findings indicate a broad failure to adhere to cGMP requirements, posing potential risks to product quality and patient safety.